» Articles » PMID: 18201639

Use of Smoking-cessation Treatments in the United States

Overview
Journal Am J Prev Med
Specialty Public Health
Date 2008 Jan 19
PMID 18201639
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Health promotion efforts encourage smokers to quit and to use effective cessation treatments. Randomized controlled trials demonstrate that medications and behavioral treatments improve cessation rates, but retrospective surveys have been inconsistent. This study assessed frequency of quit attempts, use of treatments for cessation, and abstinence rates among treatment users and non-users.

Methods: Data were analyzed from the 2003 Tobacco Use Special Cessation Supplement to the Current Population Survey. Participants included 29,537 U.S. smokers aged > or =18 years who smoked daily 12 months before the survey. Outcome measures included past-year quit attempts; use of behavioral, pharmacologic, and alternative treatments; receipt of social support; and abstinence for > or =4 weeks at time of survey.

Results: Approximately 43.5% of smokers reported a quit attempt in the preceding year: 64.2% of attempters used no cessation treatments; 8.8% used behavioral treatment; 32.2% used medication; and 14.1% used more than one treatment. Social support was reported to have been received by 24.1%. More nicotine-dependent smokers were more likely to use medications (OR=3.58; 95% CI=3.04-4.20). At the time of the survey, 19.3% of attempters were abstinent > or =4 weeks. Smokers who sought treatment were less likely to be abstinent (OR=0.75; 95% CI=0.67-0.84), and those who sought multiple treatments were even less likely to be abstinent.

Conclusions: Many U.S. smokers make quit attempts, but most do not use behavioral or pharmacologic treatments. More nicotine-dependent smokers were more likely to seek treatment. Smokers who sought treatment were less likely to report abstinence, probably due to biased self-selection and recall. Retrospective survey data are not well-suited to assess the effectiveness of treatment.

Citing Articles

In-Person versus Virtual CEASE Smoking Cessation Interventions.

Sheikhattari P, Barsha R, Egboluche C, Foster A, Assari S J Biomed Life Sci. 2024; 4(2):71-80.

PMID: 39575231 PMC: 11580340. DOI: 10.31586/jbls.2024.1107.


Is unassisted smoking cessation choice and success associated with high mental stress? Evidence from six cities in China.

Yang T, Cottrell R, Wu D Tob Induc Dis. 2024; 22.

PMID: 39403276 PMC: 11472349. DOI: 10.18332/tid/193606.


Factors Associated with Recent Use of Nicotine Replacement Therapy Among Multiethnic Smokers Residing in Public Housing.

Geller A, Borrelli B, Davine J, Burtner J, Heeren T, Rees V J Smok Cessat. 2024; 13(3):162-170.

PMID: 38911966 PMC: 11193361. DOI: 10.1017/jsc.2017.21.


An Integrated mHealth App for Smoking Cessation in Black Smokers With HIV: Protocol for a Randomized Controlled Trial.

Bizier A, Jones A, Businelle M, Kezbers K, Hoeppner B, Giordano T JMIR Res Protoc. 2024; 13:e52090.

PMID: 38657227 PMC: 11079772. DOI: 10.2196/52090.


Gender, smoking, and tobacco cessation with pharmacological treatment in a cluster randomized clinical trial.

Minue-Lorenzo C, Olano-Espinosa E, Minue-Estirado M, Vizcaino-Sanchez J, Camarelles-Guillem F, Granados-Garrido J Tob Induc Dis. 2024; 22.

PMID: 38362269 PMC: 10867739. DOI: 10.18332/tid/177260.